{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:12:37Z","timestamp":1765545157896,"version":"3.37.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1124\/jpet.102.036921","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:46:56Z","timestamp":1042224416000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Primaquine-Induced Hemolytic Anemia: Effect of 6-Methoxy-8-hydroxylaminoquinoline on Rat Erythrocyte Sulfhydryl Status, Membrane Lipids, Cytoskeletal Proteins, and Morphology"],"prefix":"10.1016","volume":"303","author":[{"given":"Laura J.C.","family":"Bolchoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Jollow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.036921_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-2952(91)90005-P","volume":"41","author":"Agarwal","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.036921_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/jm00369a031","article-title":"Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes.","volume":"27","author":"Allahyari","year":"1984","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.102.036921_bib3","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/0006-2952(88)90042-1","article-title":"Direct ESR detection of a free radical intermediate during the peroxidase-catalyzed oxidation of the antimalarial drug primaquine [published erratum appears in Biochem Pharmacol (1988) 37: 4033].","volume":"37","author":"Augusto","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.036921_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0031-6997(25)06872-3","article-title":"Drug-induced hemolytic anemia.","volume":"21","author":"Beutler","year":"1969","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.102.036921_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(24)29564-1","article-title":"Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.","volume":"297","author":"Bolchoz","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.036921_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0272-6386(01)80130-X","article-title":"Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes.","volume":"37","author":"Bonomini","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.102.036921_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0891-5849(96)00542-4","article-title":"Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine.","volume":"22","author":"Bradshaw","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/jpet.102.036921_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0300-9084(98)80024-2","article-title":"Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review.","volume":"80","author":"Bratosin","year":"1998","journal-title":"Biochimie"},{"key":"10.1124\/jpet.102.036921_bib9","first-page":"165","article-title":"The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency.","volume":"35","author":"Degowin","year":"1966","journal-title":"Bull WHO"},{"key":"10.1124\/jpet.102.036921_bib10","first-page":"30","article-title":"The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.","volume":"45","author":"Dern","year":"1955","journal-title":"J Lab Clin Med"},{"key":"10.1124\/jpet.102.036921_bib11","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/bi00789a030","article-title":"Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.","volume":"10","author":"Fairbanks","year":"1971","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.102.036921_bib12","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/0006-2952(88)90263-8","article-title":"Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.","volume":"37","author":"Fletcher","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.036921_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.1979.tb03717.x","article-title":"Favism: erythrocyte metabolism during haemolysis and reticulocytosis.","volume":"43","author":"Gaetani","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.102.036921_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0022-3565(25)24263-X","article-title":"Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.","volume":"244","author":"Grossman","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.036921_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0041-008X(92)90239-O","article-title":"Dapsone-induced hemolytic anemia: effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes.","volume":"117","author":"Grossman","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.102.036921_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0022-3565(25)24384-1","article-title":"Role of aniline metabolites in aniline-induced hemolytic anemia.","volume":"238","author":"Harrison","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.036921_bib17","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1016\/S0021-9258(17)43104-8","article-title":"The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes.","volume":"259","author":"Jain","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.036921_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-008X(91)90128-2","article-title":"The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia.","volume":"111","author":"Jensen","year":"1991","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.102.036921_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/03602539509029818","article-title":"Dapsone-induced hemolytic anemia.","volume":"27","author":"Jollow","year":"1995","journal-title":"Drug Metab Rev"},{"key":"10.1124\/jpet.102.036921_bib20","series-title":"Biomarkers. Medical and Workplace Applications","first-page":"227","article-title":"Ethnic variation and genetic susceptibility: glucose-6-phosphate dehydrogenase deficiency","author":"Jollow","year":"1998"},{"year":"1974","series-title":"Methemoglobinemia: A Comprehensive Treatise.","author":"Kiese","key":"10.1124\/jpet.102.036921_bib21"},{"key":"10.1124\/jpet.102.036921_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0041-008X(85)90155-3","article-title":"Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates.","volume":"81","author":"Link","year":"1985","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.102.036921_bib23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1203\/00006450-198211000-00005","article-title":"Properties of vitamin E-deficient erythrocytes following peroxidant injury.","volume":"16","author":"Lubin","year":"1982","journal-title":"Pediatr Res"},{"key":"10.1124\/jpet.102.036921_bib24","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.133.5.2610","article-title":"Naturally occurring autoantibodies to exoplasmic and cryptic regions of band 3 protein, the major integral membrane protein of human red blood cells.","volume":"133","author":"Lutz","year":"1984","journal-title":"J Immunol"},{"key":"10.1124\/jpet.102.036921_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0026-895X(25)09975-4","article-title":"Aniline-, phenylhydroxylamine-, nitrosobenzene- and nitrobenzene-induced hemoglobin thiyl free radical formation in vivo and in vitro.","volume":"37","author":"Maples","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.102.036921_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.cb.01.110185.002531","article-title":"Stabilizing infrastructure of cell membranes.","volume":"1","author":"Marchesi","year":"1985","journal-title":"Annu Rev Cell Biol"},{"key":"10.1124\/jpet.102.036921_bib27","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1073\/pnas.83.10.3311","article-title":"Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages.","volume":"83","author":"McEvoy","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.036921_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/toxsci\/62.2.353","article-title":"Favism: effect of divicine on rat erythrocyte sulfhydryl status, hexose monophosphate shunt activity, morphology and membrane skeletal proteins.","volume":"62","author":"McMillan","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.102.036921_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-4684-5877-0_44","article-title":"Contribution of 3,4-dichlorophenylhydroxylamine in propanil-induced hemolytic anemia.","volume":"283","author":"McMillan","year":"1991","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/jpet.102.036921_bib30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-3565(24)37874-7","article-title":"Role of lipid peroxidation in dapsone-induced hemolytic anemia.","volume":"287","author":"McMillan","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.036921_bib31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0022-3565(25)10682-4","article-title":"Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes.","volume":"274","author":"McMillan","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.036921_bib32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10715769809065821","article-title":"Measurement of lipid peroxidation.","volume":"28","author":"Moore","year":"1998","journal-title":"Free Radic Res"},{"key":"10.1124\/jpet.102.036921_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(99)00106-8","article-title":"Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.","volume":"300","author":"Morrow","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.102.036921_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/014107689909200705","article-title":"The evolution of tafenoquine\u2014antimalarial for a new millennium?","volume":"92","author":"Peters","year":"1999","journal-title":"J R Soc Med"},{"key":"10.1124\/jpet.102.036921_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0002-9343(66)90032-5","article-title":"Destruction of injured red cells in vivo.","volume":"41","author":"Rifkind","year":"1966","journal-title":"Am J Med"},{"key":"10.1124\/jpet.102.036921_bib36","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood.V25.6.885.885","article-title":"Heinz body anemia: an ultrastructural study.","volume":"25","author":"Rifkind","year":"1965","journal-title":"Blood"},{"key":"10.1124\/jpet.102.036921_bib37","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1016\/S0021-9258(17)44422-X","article-title":"Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells. Recognition by autologous macrophages.","volume":"258","author":"Tanaka","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.036921_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archinte.1962.03620140081013","article-title":"Primaquine sensitivity.","volume":"109","author":"Tarlov","year":"1962","journal-title":"Arch Intern Med"},{"key":"10.1124\/jpet.102.036921_bib39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1086\/514696","article-title":"Clindamycin with primaquine vs. trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.","volume":"27","author":"Toma","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1124\/jpet.102.036921_bib40","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"965","article-title":"Drugs used in the chemotherapy of protozoal infections: malaria","author":"Tracy","year":"1996"},{"key":"10.1124\/jpet.102.036921_bib41","doi-asserted-by":"crossref","first-page":"23611","DOI":"10.1016\/S0021-9258(18)54327-1","article-title":"Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition and phagocytosis.","volume":"266","author":"Turrini","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.036921_bib42","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/bi00380a041","article-title":"Partial characterization of the copolymerization reaction of erythrocyte membrane band 3 with hemichromes.","volume":"26","author":"Waugh","year":"1987","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.102.036921_bib43","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI112696","article-title":"Heinz bodies induce clustering of band 3, glycophorin and ankyrin in sickle cell erythrocytes.","volume":"78","author":"Waugh","year":"1986","journal-title":"J Clin Investig"},{"key":"10.1124\/jpet.102.036921_bib44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood.V89.4.1121","article-title":"Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.","volume":"89","author":"Zwaal","year":"1997","journal-title":"Blood"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652435918X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652435918X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.036921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:27:57Z","timestamp":1740007677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652435918X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S002235652435918X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.036921","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primaquine-Induced Hemolytic Anemia: Effect of 6-Methoxy-8-hydroxylaminoquinoline on Rat Erythrocyte Sulfhydryl Status, Membrane Lipids, Cytoskeletal Proteins, and Morphology","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.036921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}